Synthesis of α-galactosyl epitopes by recombinant α1,3galactosyltransferase for opsonization of human tumor cell vaccines by anti-galactose

Cancer Research

Volumn 56, Issue 13, 1996, Pages 3069-3074

  LaTemple, Denise C ^a   Henion, Timothy R ^a   Anaraki, Farvardin ^a   Galili, Uri ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FC RECEPTOR; FETUIN; GALACTOSE; GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; TUMOR ANTIGEN; TUMOR CELL VACCINE;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELL MEMBRANE; HUMAN; HUMAN CELL; IMMUNOGENICITY; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL;

ALPHA-FETOPROTEINS; ANIMALS; CARBOHYDRATE SEQUENCE; EPITOPES; GALACTOSE; GALACTOSIDES; GALACTOSYLTRANSFERASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY, ACTIVE; MACROPHAGES; MOLECULAR SEQUENCE DATA; NEOPLASMS; OPSONIN PROTEINS; PHAGOCYTOSIS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; VACCINES;

EID: 0029942885     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Berd, D., Maguire, H. C , Jr , McCue, P., and Mastrangelo, M. J Treatment of metastatic melanoma with an autologous tumor cell vaccine: clinical and immunologic results in 64 patients. J Clin. Oncol., 8: 1858-1867, 1990.
2. Hoover, H. C., Jr., Brandhurst, J S., Peters, L. C., Surdyke, M. G., Takeshita, Y., Madariaga, J., Muenz, L R., and Hanna, M. G., Jr. Prospective randomized trial of adjuvant active specific immunotherapy for human colorectal cancer. Cancer (Phila.), 55: 1236-1243, 1985.
3. Pardoll, D. M Tumor antigens: a new look for the 1990s. Nature (Lond.), 369: 357-358, 1994.
4. Lanzavecchia, A Identifying strategies for immune intervention. Science (Washington DC), 260: 937-944, 1993.
5. Nossal, G. J. V Tolerance and ways to break it. Ann. NY Acad. Sci., 690. 34-41, 1993
6. Stoner, R. D., and Terres, G. Enhanced antitoxin responses in irradiated mice elicited by complexes of tetanus toxoid and specific antibody. J. Immunol., 91: 761-770, 1973.
7. Houston, W E., Kremer, R. J., and Crabbs, C. L. Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: enhanced primary immune response and altered pattern of antibody class elicited J. Infect. Dis., 135: 600-610, 1977.
8. Sinclair, N. R. Modulation of immunity by antibody, antigen antibody complexes and antigen. Pharmacol Ther., 4. 355-432, 1979.
9. Celis, E., and Chang, T. W. Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen. Science (Washington DC), 224: 297-299, 1984.
10. Celis, E., Abraham, K. G., and Miller, R. W. Modulation of the immunological response to hepatitis B virus by antibodies. Hepatology, 7: 563-568, 1987
11. Manca, F , Fenoglio, D., LiPira, G., Kunkl, A., and Celada, F. Effect of antigen/ antibody ratio on macrophage uptake, processing and presentation to T cells of antigen complexed with polyclonal antibodies. J Exp Med., 173: 37-48, 1991.
12. Gosselin, E J., Wardwell, K., Gosselin, D. R., Alter, N., Fischer, J. L., and Guyre, P. M. Enhanced antigen presentation using human Fcγ receptor (monocyte/macrophage)-specific immunogens. J. Immunol., 149: 3477-3481, 1992
13. Unanue, E. R. Antigen presenting function of macrophages. Ann. Rev. Immunol., 2: 395-428, 1985.
14. Schmitt, D. A., Hanau, D., Bieber, T., Dezutter-Dambuyant, C., Schmitt, D., Fabre, M., Pauly, G., and Cazenave, J. P. Human epidermal Langerhans cells express only the 40-kilodalton Fcγ receptor (FcRII). J Immunol., 144. 4284-4290, 1990.
15. Tew, J. G., Kosco, M. H., Burton, G F , and Szakal, A. K. Follicular dendritic cells as accessory cells. Immunol. Rev., 117: 185-211, 1990.
16. Metlay, J. P., Pure, H., and Steinman, R. M. Distinct features of dendritic cells and anti-immunoglobulin activated B cells as stimulators of the primary mixed leukocyte reaction. J. Exp. Med., 169: 239-254, 1989
17. Galili, U., Rachmilewitz, E. A., Peleg, A., and Flechner, I A unique natural human IgG antibody with anti-α-galaetosyl specificity. J. Exp. Med , 160: 1519-1531, 1984.
18. Davin, J. C., Malaise, M , Foidart, J. M., and Mahieu, P. Anti-α-galactosyl antibodies and immune complexes in children with Henoch-Schönlem purpura or IgA nephropathy Kidney Int , 31 1132-1139, 1987.
19. Galili, U., Mandrell, R E , Hamadeh, R. M., Shohet, S. B., and Griffiss, J. M. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun., 56. 1730-1737, 1988
20. Galili, U , Macher, B A., Buehler, J., and Shohet, S. B Human natural anti-α-galactosyl IgG II. The specific recognition of α-(1→3)-linked galactose residues. J. Exp. Med , 162: 573-582, 1985.
21. Galili, U , Buehler, J., Shohet, S. B , and Macher, B. A The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J. Exp. Med., 165. 693-704, 1987.
22. Galili, U. Evolution and pathophysiology of the human natural anti-α-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol., 15 155-171, 1993
23. Galili, U , Clark, M. R., Shohet, S. B., Buehler, J., and Macher, B A. Evolutionary relationship between the anti-Gal antibody and the Galα1→3Gal epitope in primates. Proc Natl. Acad Sci. USA, 84: 1369-1373, 1987.
24. Galili, U., Shohet, S. B., Kobrin, E., Stults, C. L. M., and Macher, B. A. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol. Chem , 263: 17755-17762, 1988
25. Basu, M., and Basu, S. Enzymatic synthesis of a blood group-related pentaglycosyl ceramide by an α-galactosyltransferase from rabbit bone marrow. J Biol Chem., 248. 12700-12706, 1973
26. Blake, D D , and Goldstein, I. J. An α-D-galactosyltransferase in Ehrlich ascites tumor cells. Biosynthesis and characterization of a trisaccharide (α-D-galactose(1-3)-N-acetyllactosamine) J Biol. Chem., 265: 5387-5393, 1981
27. Blanken, W M , and van den Eijnden, D. H. Biosynthesis of terminal Galα1-3Galβ1-4GlcNAc-R oligosaccharide sequences on glycoconjugates Purification and acceptor specificity of a UDP-Gal: N-acetyllactosamine α1,3galactosyltransferase from calf thymus. J. Biol Chem., 260: 12927-12934, 1985.
28. Joziasse, D. H., Shaper, J H., Van den Eijnden, D H , Van Tunen, A. J., and Shaper, N L. Bovine α1-3galactosyltransferase: isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA J Biol. Chem., 264: 14290-14297, 1989
29. Larsen, R D., Rivera-Marrero, C. A , Ernst, L. K., Cummings, R. D., and Lowe, J. B Frameshift and nonsense mutations in human genomic sequence homologous to a murine UDP-Gal β-D-Gal(1,4)-D-GlcNAc α(1,3)-galactosyltransferase. J. Biol. Chem , 265: 7055-7061, 1990
30. Joziasse, D H , Shaper, J. H., Jabs, E. W., and Shaper, N. L. Characterization of an α1,3galactosyltransferase homologue in human chromosome 12 that is organized as a processed pseudogene. J Biol. Chem., 266: 6991-6998, 1991.
31. Galili, U , and Swanson, K. Gene sequences suggest inactivation of α1-3galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc. Natl. Acad Sci USA, 88: 7401-7404, 1991.
32. Galili, U., and Andrews, P Suppression of α-galactosyl epitopes synthesis and production of the natural anti-Gal antibody: a major evolutionary event in ancestral Old World primates. J Hum. Evol., 29: 433-443, 1995
33. Larsen, R. D , Rajan, V. P , Ruff, M., Kukowska-Latallo, J , Cummings, R. D., and Lowe, J B Isolation of cDNA encoding a murine UDP-galactose. β-D-galactosyl-1,4-N-acetyl-D-glucosamine α1,3galactosyltransferase: expression cloning by gene transfer Proc. Natl. Acad Sci. USA, 86 8227-8231, 1989.
34. Sandrin, M. S., Dabkowski, P. L., Henning, M. M , Mouthouris, E., and McKenzie, I. F. C. Characterization of cDNA clones for porcine α(1,3)galactosyltransferase: the enzyme generating the Galα(1,3)Gal epitope. Xenotransplantation, 1: 81-88, 1994.
35. Strahan, K M., Gu, F , Preece, A. F., Gustavsson, I., Andersson, L , and Gustafsson, K. cDNA sequence and chromosome localization of pig α1,3galactosyltransferase Immunogenetics, 41: 101-105, 1995.
36. Henion, T R., Macher, B. A., Anaraki, F , and Galili, U. Defining the minimal size of catalytically active primate α1,3galactosyltransferase: structure function studies on the recombinant truncated enzyme Glycobiology, 4: 193-201, 1994.
37. Lang, B., Valtieri, M., Santoli, D., Carcciolo, S., Mavilio, F., Gemperline, I., Griffin, C , Emanuel, B., Finan, J , Nowell, P., and Rovera, G. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF dependent cell lines. Blood, 70: 192-199, 1987.
38. Spiro, R. G. Periodate oxidation of the glycoprotein fetuin J Biol Chem., 239: 567-573, 1964.
39. Nillson, B., Norden, N. E., and Svensson, S. Structural studies on the carbohydrate portion of fetuin. J Biol Chem., 254: 4545-4553, 1979.
40. Takasaki, S., and Kobata, A Asparagine-linked sugar chains of fetuin: occurrence of tetrasialyl triantennary sugar chains containing the Galβ1→GlcNAc sequence Biochemistry, 25: 5709-5715, 1986.
41. 1H NMR spectroscopy. J. Biol. Chem., 263: 18253-18268, 1988.
42. Galili, U., and Anaraki, F α-Galactosyl (Galα1-3Galβ1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate α1,3galactosyltransferase expressed in E. coli. Glycobiology, 5: 783-790, 1995.
43. Kornfeld, R , and Kornfeld, S. Structure of glycoproteins and their oligosaccharide units. In: W. J Lennarz (ed.), Biochemistry of Glycoproteins and Proteoglycans, pp 1-34. New York, Plenum Publishing Corp , 1980.
44. Hakamon, S. Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism and their developmental change Semin. Hematol., 18: 39-62, 1981
45. Wood, C , Kabat, E. A., Murphy, L A., and Goldstein, I. J Immunochemical studies of the combining sites of two isolectins A4 and B4 isolated from Bandeiraea simplicifolia. Arch. Biochem. Biophys., 198: 1-10, 1979
46. Galili, U., Repik, P. M., Anaraki, F., Mozdzanowska, K., Washko, G., and Gerhard, W Enhancement of antigen presentation of influenza virus hemagglutinin by the natural anti-Gal antibody. Vaccine, 14: 321-328, 1996.
47. Galli, U Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans Immunol. Today, 14: 480-482, 1993.
48. Good, A. H., Cooper, D. C. K., Malcolm, A J., Ippolito, R. M , Koren, E., Neethling, F. A., Ye, Y , Zuhdi, N., and Lamontage, L. R. Identification of carbohydrate structures that bind human anti-porcine antibodies: implications for discordant xenografting in humans Transplant Proc., 24: 559-562, 1992
49. Sandrin, M , Vaughan, H. A , Dabkowski, P. L , and McKenzie, I F C. Anti-pig IgM antibodies in human serum react predominantly with Galα1-3Gal epitopes Proc. Natl. Acad Sci. USA, 90. 11391-11395, 1993.
50. Collins, B. H., Cotterell, A. H , McCurry, K R., Alvarado, C G., Magee, J. C., Parker, W., and Platt, J. L. Cardiac xenografts between primate species provide evidence for the importance of α-galactosyl determinant in hyperacute rejection. J. Immunol., 154: 5500-5510, 1995.
51. Joziasse, D. H , Shaper, N. L , Slayer, L. S., van den Eijnden, D. H., van der Spoel, A C., and Shaper, J. H α1,3Galactosyltransferase: the use of recombinant enzyme for the synthesis of α-galactosylated glycoconjugates. Eur. J. Biochem., 191: 75-83, 1990
52. Dranoff, G., Jaffee, E , Lazenby, A , Golumbek, P., Levitzsky, H., Brose, K., Jackson, V., Harnada, H , Pardoll, D., and Mulligan, R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulate potent specific and long-lasting anti-tumor immunity. Proc. Natl. Acad. USA, 90. 3539-3543, 1993.
53. Gorelik, E , Duty, L., Anaraki, F., and Galili, U. Alteration of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by α1,3galactosyltransferase gene transfection. Cancer Res., 55, 4168-4173, 1995.